Antepartum Antibiotic Treatment Increases Offspring Susceptibility to Experimental Colitis: A Role of the Gut

Peris Mumbi Munyaka1,2, N Eissa1, Charles Noah Bernstein3,4

  • 1Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.

Plos One
|November 26, 2015
PubMed

Insights

Antepartum antibiotic exposure in mice increased offspring susceptibility to colitis by altering gut microbiota composition and function. This suggests potential long-term health implications for children born to mothers receiving antibiotics during pregnancy.

Area of Science:

  • Microbiome research
  • Immunology
  • Gastroenterology

Background:

  • Postnatal immune system maturation relies on microbial exposure.
  • Gut colonization patterns may influence childhood diseases persisting into adulthood.

Purpose of the Study:

  • To investigate if antepartum antibiotic (ATB) therapy increases offspring susceptibility to experimental colitis.
  • To determine if ATB therapy alters the gut microbiota, contributing to disease susceptibility.

Main Methods:

  • Pregnant mice received cefazolin or saline antepartum.
  • Offspring (7 weeks old) were exposed to dextran sulfate sodium (DSS) to induce colitis.
  • Gut microbiota composition (16S rRNA sequencing) and inflammatory markers (IL-6, IL-1β, CRP) were analyzed.

Main Results:

  • Antepartum antibiotics altered fecal bacterial composition and predicted functional pathways.
  • Antibiotic exposure increased colitis severity, histologic damage, and colonic IL-6 levels in offspring.
  • Microbial richness decreased, and composition shifted in fecal and colonic samples post-antibiotic exposure.

Conclusions:

  • Antepartum antibiotics modulate offspring gut microbiota, increasing susceptibility to colonic inflammation.
  • Findings support the hypothesis in a murine colitis model.
  • Results may inform interventions to restore healthy gut colonization in infants exposed to maternal antibiotics.
Abstract

Related Concept Videos